Requirements:
2.0 BACKGROUND
*Our lab studies the role of inflammation/innate resistance and commensal microbiota in carcinogenesis, cancer progression and therapy of cancer. *
*The following product features/characteristics are required for this requirement: *
**Protein Coverage - **Measures ~5,400+ human proteins simultaneously in a single workflow.
Technology - Uses Proximity Extension Assay (PEA)*** with dual antibody recognition coupled to DNA barcoding and next-generation sequencing (NGS) readout.*
**Sample input – **requires only 2 ul of plasma, serum, and other sample types
Specificity* - Reported 99.5% specificity with negligible cross-reactivity due to dual-recognition antibody design.*
Dynamic Range* - Approximately 10 orders of magnitude (fg/mL to mg/mL****)***, enabling detection of both low- and high-abundance proteins.
Key strengths
*Very broad proteome coverage while maintaining antibody-based specificity. *
*Excellent sensitivity for low-abundance circulating proteins (especially cytokines and signaling proteins). *
*Extremely low sample-volume requirement. *
Highly standardized platform, making it attractive for epidemiology and multi-omics studies.
Source: SAM.gov (notice 0bcdbebf6ffc4be299a63e6ac5baa36f), retrieved via the SAM.gov Get Opportunities API. View the official posting — always confirm requirements and deadlines with the issuing agency.
Here are some similar opportunities
Let our AI help you find the right opportunity
Search with AI →